What drove the 1EZ0.F stock drop on 12 Mar 2026?

The drop reflected weak fundamentals, negative EPS (**-88.61**), low liquidity, and short-term selling pressure. Volume was **1,944**, below average, amplifying price moves. Sector underperformance and balance-sheet concerns also contributed to selling.

What is Meyka AI's price forecast for 1EZ0.F stock?

Meyka AI's forecast model projects a 12-month base-case price **€0.01** (implied **-50.25%** vs **€0.0201**) and a bull-case **€0.05** (implied **+148.81%**). Forecasts are model-based projections and not guarantees.

Is 1EZ0.F stock a buy after this decline?

Given negative margins, EPS **-88.61**, and low liquidity, we view the stock as high risk. Meyka AI’s grade is **B / HOLD**. Investors seeking exposure should use small sizes and strict risk controls.

Where can I find company filings for Europlasma (1EZ0.F)?

Europlasma corporate disclosures and news are on the company site [Europlasma website](https://www.europlasma.com). For market data and profiles use recognized data providers and the XETRA feed.

DE Stocks

1EZ0.F Europlasma down 23% to €0.02 on XETRA 12 Mar 2026: risks remain

ByDanny Kontos March 13, 2026March 13, 2026

1EZ0.F stock plunged -23.28% to EUR 0.0201 on XETRA as the market closed on 12 Mar 2026, marking it among today’s top losers. We tracked a thin session with volume 1,944 and a low of €0.0201, versus a previous close of €0.0262. Traders cited poor fundamentals and low liquidity; the shares trade far below their 50-day average of €0.09 and 200-day average of €4.68. This report breaks down price action, fundamentals, technicals, Meyka AI grading, and a model-based forecast to guide market participants.